
GC Therapeuticsrevenue
Cambridge, MassachusettsFounded 2019CEO Edward Trahearn
GC Therapeutics (GCTx) uses synthetic biology to program patient-derived stem cells into various cell types in an efficient and scalable manner, aiming to revolutionize treatment across a broad range of therapeutic areas.
GC Therapeutics revenue
GC Therapeutics has not published its revenue. Growjo puts it at about $9.6M a year (September 2025).
| As of | Revenue | Source |
|---|---|---|
| Sep 2025 | $9.6MEST | Growjo estimate |
GC Therapeutics CEO & employees
Edward Trahearn is CEO of GC Therapeutics. GC Therapeutics has 42 employees (September 2025, LinkedIn).
GC Therapeutics FAQ
What is GC Therapeutics' revenue?
Growjo estimates GC Therapeutics' revenue at about $9.6M a year (September 2025). The company hasn't published its own figure.
How many employees does GC Therapeutics have?
GC Therapeutics has 42 employees as of September 2025, according to LinkedIn.
Who is the CEO of GC Therapeutics?
Edward Trahearn is the CEO of GC Therapeutics.
Categories
Companies in
How this page is sourced
1 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.
Updated Sep 10, 2026Data disclaimerReport a correctionClaim this profileRun GC Therapeutics? Join the podcast